262
Participants
Start Date
January 15, 2016
Primary Completion Date
July 29, 2020
Study Completion Date
July 29, 2020
ZX008 (Fenfluramine Hydrochloride)
ZX008 drug product is an oral aqueous solution of fenfluramine hydrochloride buffered to pH 5. The product is sugar free and is intended to be compatible with a ketogenic diet.
Matching Placebo
Placebo solution for ZX008. The product is sugar free and is intended to be compatible with a ketogenic diet.
Children's Hospital of Philadelphia, Philadelphia
Instituto Neurologica Carlo Besta, Milan
Panda Neurology, Atlanta
NW FL Clinical Research Group, LLC, Gulf Breeze
Neurology and Epilepsy Research Center, Orlando
Miami Children's Hospital Brain Institute, Miami
Ospedal Policlinico Giambattista Rossi diBorga Roma, Verona
A.O Carlo Poma, Mantova
AOU Anna Meyer, Florence
Mayo Clinic, Rochester
Children's Hospital of Chicago, Chicago
Cook Children's Medical Center, Fort Worth
The Children's Hospital Colorado, Aurora
University of Utah, Salt Lake City
Phoenix Children's, Phoenix
Center for Neurosciences - Tucson, Tucson
Rady Children's Hospital San Diego, San Diego
University of California San Francisco, San Francisco
Seattle Children's Hospital, Seattle
MultiCare Institute for Research & Innovation, Tacoma
Massachusetts General Hospital, Boston
Boston Children's Hospital, Boston
Saint Barnabas Medical Center, Livingston
Melbourne Brain Centre Austin Hospital, Melbourne
Children's Health Queensland Hospital and Health Service at Lady Cilento Children's Hospital, South Brisbane
The Children's Hospital Westmead Dept. of Neurology and Neurosurgery, Westmead
Universitair Ziekenhuis Antwerpen, Antwerp
Danish National Epilepsy Centre, Dianalund
French Ref centre Necker Hospital Paris, Paris
Epilepsiezentrum / Neuropädiatrie Hedwig-von-Rittberg-Zentrum Für Kinder und Jugendliche, Berlin
Krankenhaus Mara Epilepsie-Zentrum Bethel, Bielefeld
Epilepsiezentrum Freiburg, Freiburg im Breisgau
Universitaetsklinikum Jena Klinik fuer Kinder- und Jugendmedizin Neuropaediatrie, Jena
Klinik für Neuropädiatrie Universitätsklinikum Schleswig Holstein Campus Kiel, Kiel
Kleinwachau Saechsisches Epilepsiezentrum Radeberggemeinnuetzige GmbH, Radeberg
Universitaetsklinik fuer Kinder- und Jugendmedizin Abteilung III, Tübingen
Schoen Klinik Vogtareuth Neuropaediatrie und Neurologische Rehabilitation, Epilepsiezentrum fuer Kinder und Jugendlische,Tagesklinik fuer Neuropaediatrie, Vogtareuth
Istituto Pediatrico Giannina Gaslini Dipartimento di Neurologia, Genova
Ospedale Fatebenefratelli e Oftalmico, Milan
Okayama University Hospital, Okayama
Saitama Children's Medical Center, Saitama-shi
National Epilepsy Center Shizuoka Institute, Shizuoka
Tokyo Women's Medical University Hospital, Shinjuku-ku
Hospital Sant Joande Déu, Barcelona
Hospital Ruber Internacional Primera Planta Servicio de Neurologia, Madrid
Clinica Universitaria de Navarra Fase 4. Segunda planta, Consulta de Pediatria, Pamplona
Birmingham Children Hospital, Birmingham
Institute of Neurosciences Queens Elizabeth University Hospital, Glasgow
Alder Hey Hospital, Liverpool
Evelina Hospital, London
Great Ormonnd Street Hospital for Children NHS Foundation Trust, London
Sheffield Children's Hospital, Sheffield
British Columbia Children's Hospital BCCH, Vancouver
Centre Hospitalier Universitaire Sainte-Justine, Montreal
U.O. Neurologia Dipartimento di Neuroscienze Ospedale Pediatrico Bambino Gesù, IRCS, Roma
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
INDUSTRY